133 related articles for article (PubMed ID: 27955694)
1. Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters.
de Jong TD; Blits M; de Ridder S; Vosslamber S; Wolbink G; Nurmohamed MT; Verweij CL
Arthritis Res Ther; 2016 Dec; 18(1):290. PubMed ID: 27955694
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis.
de Jong TD; Snoek T; Mantel E; van der Laken CJ; van Vollenhoven RF; Lems WF
Front Immunol; 2019; 10():902. PubMed ID: 31068954
[No Abstract] [Full Text] [Related]
3. Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab.
de Jong TD; Vosslamber S; Blits M; Wolbink G; Nurmohamed MT; van der Laken CJ; Jansen G; Voskuyl AE; Verweij CL
Arthritis Res Ther; 2015 Mar; 17(1):78. PubMed ID: 25889713
[TBL] [Abstract][Full Text] [Related]
4. The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes.
de Jong TD; Lübbers J; Turk S; Vosslamber S; Mantel E; Bontkes HJ; van der Laken CJ; Bijlsma JW; van Schaardenburg D; Verweij CL
Arthritis Res Ther; 2016 Jul; 18():165. PubMed ID: 27411379
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients.
Thurlings RM; Boumans M; Tekstra J; van Roon JA; Vos K; van Westing DM; van Baarsen LG; Bos C; Kirou KA; Gerlag DM; Crow MK; Bijlsma JW; Verweij CL; Tak PP
Arthritis Rheum; 2010 Dec; 62(12):3607-14. PubMed ID: 20722020
[TBL] [Abstract][Full Text] [Related]
6. Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy.
Wright HL; Thomas HB; Moots RJ; Edwards SW
Rheumatology (Oxford); 2015 Jan; 54(1):188-93. PubMed ID: 25125592
[TBL] [Abstract][Full Text] [Related]
7. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Rodríguez-Carrio J; López P; Alperi-López M; Caminal-Montero L; Ballina-García FJ; Suárez A
Front Immunol; 2018; 9():3085. PubMed ID: 30666255
[No Abstract] [Full Text] [Related]
8. A multi-parameter response prediction model for rituximab in rheumatoid arthritis.
de Jong TD; Sellam J; Agca R; Vosslamber S; Witte BI; Tsang-A-Sjoe M; Mantel E; Bijlsma JW; Voskuyl AE; Nurmohamed MT; Verweij CL; Mariette X
Joint Bone Spine; 2018 Mar; 85(2):219-226. PubMed ID: 28363827
[TBL] [Abstract][Full Text] [Related]
9. Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritis.
Cantaert T; van Baarsen LG; Wijbrandts CA; Thurlings RM; van de Sande MG; Bos C; van der Pouw Kraan TC; Verweij CL; Tak PP; Baeten DL
Rheumatology (Oxford); 2010 Jan; 49(1):156-66. PubMed ID: 19933783
[TBL] [Abstract][Full Text] [Related]
10. Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients.
Serikawa KA; Jacobsen S; Lundsgaard D; Fox BA; Hummelshoj L; Poulsen LK; Fleckner J; Frederiksen KS
Mod Rheumatol; 2013 Jul; 23(4):729-40. PubMed ID: 22872428
[TBL] [Abstract][Full Text] [Related]
11. Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis.
Yokoyama-Kokuryo W; Yamazaki H; Takeuchi T; Amano K; Kikuchi J; Kondo T; Nakamura S; Sakai R; Hirano F; Nanki T; Koike R; Harigai M
Arthritis Res Ther; 2020 Mar; 22(1):46. PubMed ID: 32164778
[TBL] [Abstract][Full Text] [Related]
12. Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease course.
Seyhan AA; Gregory B; Cribbs AP; Bhalara S; Li Y; Loreth C; Zhang Y; Guo Y; Lin LL; Feldmann M; Williams LM; Brennan FM; Taylor PC
Sci Rep; 2020 Jun; 10(1):8830. PubMed ID: 32483203
[TBL] [Abstract][Full Text] [Related]
13. Distinct Single Cell Gene Expression in Peripheral Blood Monocytes Correlates With Tumor Necrosis Factor Inhibitor Treatment Response Groups Defined by Type I Interferon in Rheumatoid Arthritis.
Wampler Muskardin TL; Fan W; Jin Z; Jensen MA; Dorschner JM; Ghodke-Puranik Y; Dicke B; Vsetecka D; Wright K; Mason T; Persellin S; Michet CJ; Davis JM; Matteson E; Niewold TB
Front Immunol; 2020; 11():1384. PubMed ID: 32765497
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis.
Vosslamber S; Raterman HG; van der Pouw Kraan TC; Schreurs MW; von Blomberg BM; Nurmohamed MT; Lems WF; Dijkmans BA; Voskuyl AE; Verweij CL
Ann Rheum Dis; 2011 Jun; 70(6):1153-9. PubMed ID: 21444302
[TBL] [Abstract][Full Text] [Related]
15. A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine.
Wojciechowski J; Wiese MD; Proudman SM; Foster DJ; Upton RN
Br J Clin Pharmacol; 2015 May; 79(5):777-88. PubMed ID: 25394211
[TBL] [Abstract][Full Text] [Related]
16. Identifying Clinical Factors Associated With Low Disease Activity and Remission of Rheumatoid Arthritis During Pregnancy.
Ince-Askan H; Hazes JMW; Dolhain RJEM
Arthritis Care Res (Hoboken); 2017 Sep; 69(9):1297-1303. PubMed ID: 27813290
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate.
O'Dell JR; Haire C; Erikson N; Drymalski W; Palmer W; Maloley P; Klassen LW; Wees S; Moore GF
J Rheumatol Suppl; 1996 Mar; 44():72-4. PubMed ID: 8833058
[TBL] [Abstract][Full Text] [Related]
18. Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis.
Reynier F; Petit F; Paye M; Turrel-Davin F; Imbert PE; Hot A; Mougin B; Miossec P
PLoS One; 2011; 6(10):e24828. PubMed ID: 22043277
[TBL] [Abstract][Full Text] [Related]
19. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.
van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Voskuyl AE; Rustenburg F; Baggen JM; Ibrahim SM; Fero M; Dijkmans BA; Tak PP; Verweij CL
Ann Rheum Dis; 2007 Aug; 66(8):1008-14. PubMed ID: 17223656
[TBL] [Abstract][Full Text] [Related]
20. A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.
Heimans L; Wevers-de Boer KV; Visser K; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Speyer I; de Buck MP; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
Ann Rheum Dis; 2014 Jul; 73(7):1356-61. PubMed ID: 23716067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
